June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Myocilin modulates programmed cell death during retinal development
Author Affiliations & Notes
  • Marcus Koch
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Bernd Rosenhammer
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Sebastian Koschade
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Barbara Braunger
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Cornelia Volz
    University Clinical Center, Clinic and Policlinic for Ophthalmology, Regensburg, Germany
  • Herbert Jägle
    University Clinical Center, Clinic and Policlinic for Ophthalmology, Regensburg, Germany
  • Ernst Tamm
    Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany
  • Footnotes
    Commercial Relationships Marcus Koch, None; Bernd Rosenhammer, None; Sebastian Koschade, None; Barbara Braunger, None; Cornelia Volz, None; Herbert Jägle, None; Ernst Tamm, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5154. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marcus Koch, Bernd Rosenhammer, Sebastian Koschade, Barbara Braunger, Cornelia Volz, Herbert Jägle, Ernst Tamm; Myocilin modulates programmed cell death during retinal development. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5154.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate the role of myocilin for programmed cell death in the mouse retina. Myocilin is a secreted glycoprotein of the olfactomedin family that modulates Wnt-signaling. The biological function(s) of myocilin are largely unclear. Mutations in myocilin are causative for some forms of glaucoma.

Methods: Myocilin-deficient mice (Myoc-/-) and Myoc-/-; βB1-Crystallin-Myocilin mice with ocular overexpression of myocilin were characterized and analyzed by real-time RT-PCR, semithin sectioning and electroretinography (ERG). Apoptosis of retinal neurons during development was visualized by TUNEL-labeling and quantified. Western blotting was used to investigate pJNK, Wnt/β-catenin, TGF-β and PI3K-Akt signaling. In vitro experiments were performed with RGC-5 cells treated with recombinant myocilin, or myocilin in combination with specific antibodies against it.

Results: During postnatal synaptogenesis (postnatal days (P) 4, 9 and 14), apoptotic death of retinal neurons throughout the different layers of the retina was significantly decreased in Myoc-/- pups. The decrease in developmental programmed cell death resulted in a significantly lower number of retinal ganglion cell (RGC) perikarya and their axons in the optic nerve, as well as in a decreased thickness of outer and inner nuclear layer in adult Myoc-/- mice when compared to wild-type littermates. Moreover, ERG of Myoc-/- mice showed a reduction of the b-wave under scoptopic conditions. In contrast, myocilin-deficient mice with simultaneous ectopic overexpression of myocilin from the lens (Myoc-/-; βB1-Crystallin-Myocilin) did not show differences in retinal structure or developmental apoptosis when compared to wild-type mice. In vitro, recombinant myocilin promoted apoptosis of RGC-5 cells, an effect that could be blocked by myocilin antibodies. The amounts of pJNK were decreased in P10 Myoc-/- mice when compared to wild-type animals, while no differences were observed when canonical Wnt/β-catenin, TGF-β of PI3K-Akt signaling were investigated.

Conclusions: Myocilin modulates programmed cell death during retinal development, an effect that involves pJNK signaling.

Keywords: 698 retinal development • 615 neuroprotection • 449 cell survival  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×